Cargando…
Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers
BACKGROUND: Hormone therapy (HT) is commonly given to women to alleviate the climacteric symptoms associated with menopause. There is concern that this treatment may increase the risk of breast cancer. The potential association of HT and breast cancer risk is of particular interest to women who carr...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556701/ https://www.ncbi.nlm.nih.gov/pubmed/18812548 http://dx.doi.org/10.1093/jnci/djn313 |